Optimizing Smoking Cessation for People With HIV/AIDS Who Smoke
Status:
Completed
Trial end date:
2021-04-01
Target enrollment:
Participant gender:
Summary
The single greatest health behavior change that could improve cardiovascular morbidity and
associated mortality is to assist people living with HIV/AIDS who smoke to quit. The
investigators will use a factorial design to evaluate the most promising behavioral and
pharmacologic treatments aimed at achieving maximal efficacy for smoking cessation among
people living with HIV/AIDS who smoke. Results of this study will provide crucial, real world
evidence of the best way for healthcare providers to help smokers living with HIV/AIDS quit
smoking.
Phase:
Phase 3
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore